BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31736563)

  • 21. Prevalence of Impulsive-Compulsive Symptoms in Elderly Parkinson's Disease Patients: A Case-Control Study.
    Lo Monaco MR; Petracca M; Weintraub D; Fusco D; Liperoti R; Zuccalà G; La Carpia D; Vetrano DL; Genovese D; Pisciotta MS; Brandi V; Padua L; Imbimbo I; Ricciardi D; Bernabei R; Silveri MC; Laudisio A; Bentivoglio AR
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29702754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease.
    Weintraub D; Hoops S; Shea JA; Lyons KE; Pahwa R; Driver-Dunckley ED; Adler CH; Potenza MN; Miyasaki J; Siderowf AD; Duda JE; Hurtig HI; Colcher A; Horn SS; Stern MB; Voon V
    Mov Disord; 2009 Jul; 24(10):1461-7. PubMed ID: 19452562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Korean Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale.
    Choi JH; Lee JY; Cho JW; Ko SB; Ahn TB; Kim SJ; Cheon SM; Kim JS; Kim YJ; Ma HI; Baik JS; Lee PH; Chung SJ; Kim JM; Song IU; Kim HJ; Sung YH; Kwon DY; Lee JH; Kim JY; Kim JS; Yun JY; Kim HJ; Hong JY; Kim MJ; Youn J; Kim JS; Oh ES; Yang HJ; Yoon WT; You S; Kwon KY; Park HE; Lee SY; Kim Y; Kim HT; Park MY
    J Clin Neurol; 2020 Apr; 16(2):245-253. PubMed ID: 32319241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of Impulsivity on Quality of Life in Early Drug-Naïve Parkinson's Disease Patients.
    Ryu DW; Kim JS; Yoo SW; Oh YS; Lee KS
    J Mov Disord; 2019 Sep; 12(3):172-176. PubMed ID: 31390856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and Neuroanatomical Account of Impulsivity in Parkinson's Disease.
    Hlavatá P; Linhartová P; Šumec R; Filip P; Světlák M; Baláž M; Kašpárek T; Bareš M
    Front Neurol; 2019; 10():1338. PubMed ID: 31998210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single versus multiple impulse control disorders in Parkinson's disease: an ¹¹C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release.
    Wu K; Politis M; O'Sullivan SS; Lawrence AD; Warsi S; Bose S; Lees AJ; Piccini P
    J Neurol; 2015 Jun; 262(6):1504-14. PubMed ID: 25893253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring brain changes of impulse control disorders in Parkinson's disease: An ALE study.
    Gu L; Shu H; Wang Y; Xu H
    Front Aging Neurosci; 2022; 14():966525. PubMed ID: 36110428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Cortical Thickness in Patients With Early Parkinson's Disease at Different Hoehn and Yahr Stages.
    Gao Y; Nie K; Mei M; Guo M; Huang Z; Wang L; Zhao J; Huang B; Zhang Y; Wang L
    Front Hum Neurosci; 2018; 12():469. PubMed ID: 30542273
    [No Abstract]   [Full Text] [Related]  

  • 29. Problematic Internet use in Parkinson's disease.
    Wu K; Politis M; O'Sullivan SS; Lawrence AD; Warsi S; Lees A; Piccini P
    Parkinsonism Relat Disord; 2014 May; 20(5):482-7. PubMed ID: 24582704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability.
    Papay K; Mamikonyan E; Siderowf AD; Duda JE; Lyons KE; Pahwa R; Driver-Dunckley ED; Adler CH; Weintraub D
    Parkinsonism Relat Disord; 2011 Mar; 17(3):153-5. PubMed ID: 21186135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Papay K; Xie SX; Stern M; Hurtig H; Siderowf A; Duda JE; Minger J; Weintraub D
    Neurology; 2014 Aug; 83(9):826-33. PubMed ID: 25037206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impulse control disorders in Parkinson's disease: A cohort of 35 patients].
    Carrière N; Kreisler A; Dujardin K; Destée A; Defebvre L
    Rev Neurol (Paris); 2012 Feb; 168(2):143-51. PubMed ID: 22129474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson's Disease and Their First-Degree Unaffected Relatives.
    Thaler A; Kliper E; Maidan I; Herman T; Rosenberg-Katz K; Bregman N; Gurevich T; Shiner T; Hausdorff JM; Orr-Urtreger A; Giladi N; Mirelman A
    Brain Topogr; 2018 Nov; 31(6):1029-1036. PubMed ID: 29846835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resting state oscillations suggest a motor component of Parkinson's Impulse Control Disorders.
    Spay C; Meyer G; Lio G; Pezzoli G; Ballanger B; Cilia R; Boulinguez P
    Clin Neurophysiol; 2019 Nov; 130(11):2065-2075. PubMed ID: 31541984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between metabolic syndrome components and impulse control disorders in Parkinson's disease.
    Chen L; He X; Tao T; Chen L; Chen Y; Mao L; Liu P
    Front Neurosci; 2023; 17():1191338. PubMed ID: 37274186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortical thinning is associated with disease stages and dementia in Parkinson's disease.
    Zarei M; Ibarretxe-Bilbao N; Compta Y; Hough M; Junque C; Bargallo N; Tolosa E; Martí MJ
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):875-81. PubMed ID: 23463873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impulse Control Disorders in Parkinson's Disease: From Bench to Bedside.
    Augustine A; Winstanley CA; Krishnan V
    Front Neurosci; 2021; 15():654238. PubMed ID: 33790738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Impulse Control Disorders (ICDs) and Factors Associated with Their Development in a Parkinson's Disease Population.
    García-Rubio MI; Otero-Cerdeira ME; Toledo-Lozano CG; Alcaraz-Estrada SL; Suárez-Cuenca JA; Coral-Vázquez RM; Mondragón-Terán P; Pineda-Juárez JA; Díaz-López LF; García S
    Healthcare (Basel); 2021 Sep; 9(10):. PubMed ID: 34682943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder.
    Fantini ML; Macedo L; Zibetti M; Sarchioto M; Vidal T; Pereira B; Marques A; Debilly B; Derost P; Ulla M; Vitello N; Cicolin A; Lopiano L; Durif F
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):174-9. PubMed ID: 25006210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease.
    Martini A; Weis L; Fiorenzato E; Schifano R; Cianci V; Antonini A; Biundo R
    Front Neurol; 2019; 10():266. PubMed ID: 30967834
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.